Ghent University Academic Bibliography

Your filters: cql: author="Monsaert, Els" or (type any "bookEditor issueEditor" and editor="Monsaert, Els")

Add to list
A forgotten cause of jaundice In a patient with alcoholic liver disease

Willem Daneels (UGent) , Sarah Debussche, Ariane Luyckx, Peter Burvenich, Didier Baert, Els Monsaert, Erik Vanderstraeten, Koen Rasquin, Pieter Dewint and Christophe Van Steenkiste (UGent)

(2015) BASL winter meeting, Abstracts.
Add to list
- Journal Article
- A1
Ischaemic necrosis of the tongue as a rare complication of cardiogenic shock

Eva Hulstaert, Eline Roggeman, Anne-Sophie Beeckman, Mieke Moerman, Erik Vanderstraeten, Koen Rasquin, Els Monsaert, Didier Baert, Pieter Dewint (UGent) , Peter Burvenich, et al.

(2015) ACTA CLINICA BELGICA. 70(6). p.436-439
Add to list
Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma

Vutha Ky, Monirath Hav (UGent) , Frederik Berrevoet (UGent) , Roberto Troisi (UGent) , Liesbeth Ferdinande (UGent) , Els Monsaert, Eric Vanderstraeten, KATRIEN DE BOSSCHERE (UGent) , Nancy Van Damme (UGent) , Stéphanie Laurent (UGent) , et al.

(2013) PANCREAS. 42(7). p.1138-1142
Add to list
- Conference Paper
- C3
Cisplatin-modified de Gramont in second line therapy for pancreatic adenocarcinoma

Vutha Ky, Monirath Hav (UGent) , Els Monsaert, Eric Vanderstraeten, D Katrien, Nancy Van Damme (UGent) , Stéphanie Laurent (UGent) and Karen Geboes (UGent)

(2012) ACTA GASTRO-ENTEROLOGICA BELGICA. 75(1).
Add to list
- Conference Paper
- C3
Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea

Alain Hendlisz, Marc Van Den Eynde, G Machiels, Isabel Dero, Karen Geboes (UGent) , Marc De Man, Koen Hendrickx, Thierry Delaunois, Els Monsaert, Eric Vanderstraeten, et al.

(2012) ACTA GASTRO-ENTEROLOGICA BELGICA. 75(1).
Add to list
- Journal Article
- A1
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study

Stéphanie Laurent (UGent) , Els Monsaert, Tom Boterberg (UGent) , A Demols, I Borbath, M Polus, A Hendlisz, Bernard de Hemptinne (UGent) , C Mahin, P Scalliet, et al.

(2009) ANNALS OF ONCOLOGY. 20(8). p.1369-1374
Add to list
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer

Wim Ceelen (UGent) , Tom Boterberg (UGent) , Piet Pattyn (UGent) , Marc Van Eijkeren (UGent) , Jean-Pierre Gillardin (UGent) , Pieter Demetter, Peter Smeets (UGent) , Nancy Van Damme (UGent) , ELS MONSAERT and Marc Peeters (UGent)

(2007) ANNALS OF SURGICAL ONCOLOGY. 14(2). p.424-431
Add to list
- Journal Article
- A1
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

A DEMOLS, Marc Peeters (UGent) , M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ and JL VAN LAETHEM

(2006) BRITISH JOURNAL OF CANCER. 94(4). p.481-485
Add to list
- Conference Paper
- C1
A retrospective analysis of the efficacy and toxicity of irinotecan and 5FU/FA in patients with advanced carcinoma of the stomach or oesophagogastric junction

ELS MONSAERT, Martine De Vos (UGent) and Marc Peeters (UGent)

(2003) ACTA GASTRO-ENTEROLOGICA BELGICA. 66.

Academic Bibliography

A forgotten cause of jaundice In a patient with alcoholic liver disease

Ischaemic necrosis of the tongue as a rare complication of cardiogenic shock

Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma

Cisplatin-modified de Gramont in second line therapy for pancreatic adenocarcinoma

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea

Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study

Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

A retrospective analysis of the efficacy and toxicity of irinotecan and 5FU/FA in patients with advanced carcinoma of the stomach or oesophagogastric junction

Contents

Support

Contact